Global Penny Stocks: Linklogis And 2 More Promising Picks

Simply Wall St

Global markets have seen a positive trend, with major U.S. stock indices like the S&P 500 and Nasdaq Composite reaching record highs, supported by strong job growth and favorable economic conditions. Amid this backdrop, investors are increasingly interested in exploring opportunities beyond traditional stocks. Penny stocks, despite their old-fashioned name, continue to offer intriguing prospects for those seeking value in smaller or newer companies with robust financials. This article will explore several penny stocks that stand out for their potential to deliver impressive returns while maintaining solid financial foundations.

Top 10 Penny Stocks Globally

NameShare PriceMarket CapRewards & Risks
EZZ Life Science Holdings (ASX:EZZ)A$2.40A$108.03M✅ 4 ⚠️ 2 View Analysis >
Lever Style (SEHK:1346)HK$1.28HK$813.93M✅ 4 ⚠️ 1 View Analysis >
Angler Gaming (NGM:ANGL)SEK3.60SEK269.95M✅ 4 ⚠️ 2 View Analysis >
CNMC Goldmine Holdings (Catalist:5TP)SGD0.43SGD174.27M✅ 4 ⚠️ 2 View Analysis >
Van Elle Holdings (AIM:VANL)£0.435£47.07M✅ 5 ⚠️ 2 View Analysis >
Yangzijiang Shipbuilding (Holdings) (SGX:BS6)SGD2.21SGD8.7B✅ 5 ⚠️ 0 View Analysis >
Bredband2 i Skandinavien (OM:BRE2)SEK2.53SEK2.42B✅ 4 ⚠️ 1 View Analysis >
DXN Holdings Bhd (KLSE:DXN)MYR0.51MYR2.54B✅ 5 ⚠️ 0 View Analysis >
Zetrix AI Berhad (KLSE:ZETRIX)MYR0.995MYR7.67B✅ 5 ⚠️ 2 View Analysis >
Croma Security Solutions Group (AIM:CSSG)£0.845£11.63M✅ 4 ⚠️ 3 View Analysis >

Click here to see the full list of 3,836 stocks from our Global Penny Stocks screener.

Here we highlight a subset of our preferred stocks from the screener.

Linklogis (SEHK:9959)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Linklogis Inc. is an investment holding company that provides supply chain finance technology and data-driven solutions in China, with a market cap of HK$3.81 billion.

Operations: The company's revenue is primarily derived from its Supply Chain Finance Technology Solutions, with CN¥663.66 million from Anchor Cloud and CN¥306.89 million from FI Cloud, complemented by Emerging Solutions contributing CN¥51.06 million through Cross-Border Cloud and CN¥9.57 million via SME Credit Tech Solutions.

Market Cap: HK$3.81B

Linklogis Inc. is navigating the penny stock landscape with a stable management team and board, both considered experienced. The company has transitioned from negative to positive shareholder equity over five years, indicating financial improvement. Despite being unprofitable, it maintains a robust cash runway exceeding three years due to positive free cash flow growth of 39.5% annually. Short-term assets significantly surpass both short-term and long-term liabilities, providing financial flexibility. While volatility remains high and earnings are forecasted to grow substantially at 130.8% per year, recent amendments in company bylaws and a declared special dividend highlight ongoing corporate activities.

SEHK:9959 Debt to Equity History and Analysis as at Jul 2025

XSpring Capital (SET:XPG)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: XSpring Capital Public Company Limited, with a market cap of THB5.89 billion, operates in the investment and securities business both in Thailand and internationally through its subsidiaries.

Operations: The company's revenue is derived from digital assets (THB18.51 million), securities business (THB10.21 million), asset management business (THB107.11 million), fund asset management business (THB132.86 million), and investment and other businesses (THB621.63 million).

Market Cap: THB5.89B

XSpring Capital demonstrates potential in the penny stock sector with a diverse revenue stream totaling THB 259.94 million for Q1 2025, showing growth from the previous year. The company's financial health is supported by short-term assets of THB7.7 billion, exceeding both short and long-term liabilities, and a reduced debt-to-equity ratio over five years. Although earnings growth has decelerated to 5.3% compared to its historical average, it still outpaces industry trends. Despite a low return on equity at 1.5% and negative operating cash flow impacting debt coverage, XSpring's experienced management team provides strategic stability amid high volatility levels.

SET:XPG Financial Position Analysis as at Jul 2025

Shenzhen Glory MedicalLtd (SZSE:002551)

Simply Wall St Financial Health Rating: ★★★★★★

Overview: Shenzhen Glory Medical Co., Ltd. offers hospital construction and medical system integrated solutions both in China and internationally, with a market cap of CN¥3.28 billion.

Operations: Shenzhen Glory Medical Co., Ltd. has not reported any specific revenue segments.

Market Cap: CN¥3.28B

Shenzhen Glory Medical Co., Ltd. presents a mixed picture in the penny stock arena. With recent profitability, the company reported Q1 2025 revenue of CNY 279.74 million and net income of CNY 13.96 million, indicating stable earnings quality despite declining earnings over five years. Financially robust, its short-term assets significantly surpass liabilities, and it has more cash than debt with improved debt-to-equity from 12.3% to 2.5%. However, return on equity remains low at 0.9%, and management experience data is insufficient for evaluation. Dividend affirmations suggest shareholder returns are prioritized amid stable volatility levels over the past year.

SZSE:002551 Financial Position Analysis as at Jul 2025

Turning Ideas Into Actions

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Valuation is complex, but we're here to simplify it.

Discover if Shenzhen Glory MedicalLtd might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.

Access Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com